The heterozygous APP p.Gly326Ser mutation may be causative of the amyloid-type CSVD, CAA—an autosomal dominant condition where amyloid progressively deposits in the cerebral blood vessel walls causing degenerative vascular changes and spontaneous cerebral haemorrhages, ischaemic lesions, and dementia [12]. The gene discussed is APP; the disease is dementia.